An economic evaluation of clopidogrel vs. aspirin in secondary prevention of ischemic events in high risk atherothrombotic patients in Italy

被引：2
|
作者：
Rudelli, G
Annemans, L
Spiesser, J
Novelli, M
Walker, A
Gabriel, S
机构：
[1] Sanofi Synthelabo, Milan, Italy
[2] HEDM, Meise, Belgium
[3] Sanofi Synthelabo Rech, Bagneux, France
[4] Bristol Myers Squibb, Rome, Italy
[5] Bristol Myers Squibb, Rueil Malmaison, France
来源：
VALUE IN HEALTH | 2004年 / 7卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)65788-9
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：686 / 687
页数：2
相关论文
共 50 条
  • [21] Aspirin vs Clopidogrel as a Monotherapy secondary prevention in Patients with Coronary Artery Disease: An updated Meta-Analysis
    Almaadawy, Omar
    Elnady, Mohamed
    Mohamed, Ahmed Almahdy
    Elshimy, Abdelrahman
    Sarhan, Menna
    Hassan, Abdul Rhman
    Moheyeldin, Eman
    Mohamed, Alshaimaa
    Ali, Nada
    Georges, Claudia
    Elsalmouny, Youmna
    Al-Azizi, Karim
    CIRCULATION, 2024, 150
  • [22] ECONOMIC EVALUATION OF SINGLE PILL COMBINATION CLOPIDOGREL: ASPIRIN VERSUS FREE COMBINATION CLOPIDOGREL PLUS ASPIRIN FOR PREVENTION OF CARDIOVASCULAR EVENTS AFTER ACUTE CORONARY SYNDROME IN CHINA
    Wu, Y.
    Wei, Q. R.
    Zhou, J.
    Guan, X.
    Wang, L. Y.
    Tan, J.
    Wang, L. J.
    Nicholls, C.
    Abdul, Jabbar O. A.
    Li, H. C.
    VALUE IN HEALTH, 2023, 26 (12) : S140 - S141
  • [23] Dual Antiplatelet Therapy Resistance to Aspirin and Clopidogrel Identifies Patients at the Highest Risk of Recurrent Atherothrombotic Events After Percutaneous Coronary Intervention
    Breet, Nicoline J.
    van Werkum, Jochem W.
    Bouman, Heleen J.
    Kelder, Johannes C.
    Hackeng, Christian M.
    ten Berg, Jurrien M.
    CIRCULATION, 2010, 122 (21)
  • [24] Identification of patients at risk of ischemic events for long-term secondary prevention
    Brassard, Andrea
    JOURNAL OF THE AMERICAN ACADEMY OF NURSE PRACTITIONERS, 2009, 21 (12): : 677 - 689
  • [25] Costs and consequences of clopidogrel versus aspirin for secondary prevention of ischaemic events in (High-Risk) atherosclerotic patients in Sweden: A lifetime model based on the CAPRIE trial and high-risk CAPRIE subpopulations
    Logman J.F.S.
    Heeg B.M.S.
    Herlitz J.
    Van Hout B.A.
    Applied Health Economics and Health Policy, 2010, 8 (4) : 251 - 265
  • [26] Evaluation of the TIMI risk score for secondary prevention for predicting ischemic and bleeding events in patients with recent myocardial infarction
    Hansen, K. W.
    Sorensen, R.
    Bjerking, L. H.
    Prescott, E.
    Galatius, S.
    EUROPEAN HEART JOURNAL, 2022, 43 : 1320 - 1320
  • [27] Economic evaluation of posaconazole vs. standard azole prophylaxis in high risk neutropenic patients in the Netherlands
    Stam, Wiro B.
    O'Sullivan, Amy K.
    Rijnders, Bart
    Lugtenburg, Elly
    Span, Lambert F. R.
    Janssen, Jeroen J. W. M.
    Jansen, Jeroen P.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2008, 81 (06) : 467 - 474
  • [28] Effect of Clopidogrel on the Rate and Functional Severity of Stroke Among High Vascular Risk Patients A Prespecified Substudy of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance (CHARISMA) Trial
    Hankey, Graeme J.
    Hacke, Werner
    Easton, J. Donald
    Johnston, S. Claiborne
    Mas, Jean-Louis
    Brennan, Danielle M.
    Bhatt, Deepak L.
    Fox, Keith A. A.
    Topol, Eric J.
    STROKE, 2010, 41 (08) : 1679 - 1683
  • [29] Impact of smoking on long-term outcomes in patients with atherosclerotic vascular disease treated with aspirin or clopidogrel: Insights from the clopidogrel versus aspirin in patients at risk of ischemic events(CAPRIE) trial
    South China Journal of Cardiology, 2013, (04) : 293 - 293
  • [30] DIFFERENTIAL EFFECTS OF SMOKING ON LONG-TERM OUTCOMES IN PATIENTS WITH ATHEROSCLEROTIC VASCULAR DISEASE TREATED WITH ASPIRIN OR CLOPIDOGREL: INSIGHTS FROM THE CLOPIDOGREL VERSUS ASPIRIN IN PATIENTS AT RISK OF ISCHEMIC EVENTS TRIAL
    Ferreiro, Jose Luis
    Bhatt, Deepak
    Ueno, Masafumi
    Bauer, Deborah
    Angiolillo, Dominick
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (13) : E257 - E257
12345